Outputs (3)

How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals (2022)
Journal Article
Moledina, Z., McPhee, M., Ravenscroft, J. C., Healy, E., Radley, K., Thomas, K. S., Burden-Teh, E., & Acne -ID Trial Development Team. (2023). How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals. Clinical and Experimental Dermatology, 48(1), 20-23. https://doi.org/10.1093/ced/llac015

We undertook a survey of UK healthcare professionals through the UKDCTN and BDNG to understand clinicians’ routine practice prescribing oral isotretinoin for treatment of acne vulgaris (acne). We also wanted to understand clinicians’ experiences and... Read More about How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals.

Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: Developing and delivering high-quality independent clinical trials (2022)
Journal Article
Williams, H. C., McPhee, M., Layfield, C., & The UK Dermatology Clinical Trials Network. (2022). Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: Developing and delivering high-quality independent clinical trials. Clinical and Experimental Dermatology, 47(6), 1048-1059. https://doi.org/10.1111/ced.15140

The UK Dermatology Clinical Trials Network (UK DCTN) was formed in 2002 with the aim of developing and supporting high-quality independent national clinical trials that address prioritized research questions for people with skin disease. Its philosop... Read More about Celebrating 20 years of the UK Dermatology Clinical Trials Network. Part 1: Developing and delivering high-quality independent clinical trials.

Future research priorities for lichen sclerosus – results of a James Lind Alliance Priority Setting Partnership (2019)
Journal Article
Simpson, R., Cooper, S., Kirtschig, G., Larsen, S., Lawton, S., McPhee, M., Murphy, R., Nunns, D., Rees, S., Tarpey, M., Thomas, K., & Lichen Sclerosus Priority Setting Partnership Steering Group. (2019). Future research priorities for lichen sclerosus – results of a James Lind Alliance Priority Setting Partnership. British Journal of Dermatology, 180(5), 1236-1237. https://doi.org/10.1111/bjd.17447